Stocktoria

SERA PROGNOSTICS, INC. SERA

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2021-07-15

SERA PROGNOSTICS, INC. statistics & valuation

Market cap$70.5M
P / B0.9×
Net margin-39417.3%
Return on equity-42.3%
FCF margin-32529.6%
Return on capital-47%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-79392.00% -42693.90% -16487.30% -11843.80% -42724.70% -39417.30% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-71884.00% -43164.60% -17034.30% -13013.40% -47577.90% -45066.70% 202020212022202320242025
Return on equity (%)
-25.30% -44.70% -51.70% -68.80% -42.30% 202020212022202320242025
Shares outstanding
1.6M 15.0M 30.9M 31.2M 33.2M 47.7M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-134.10% -23.80% -38.00% -38.00% -45.30% -31.30% 202020212022202320242025
Free cash flow margin (%)
-68068.00% -40170.70% -13209.30% -8926.80% -18500.00% -32529.60% 202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$12.76 -$2.33 -$1.43 -$1.16 -$0.99 -$0.67 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-45066.7%-47577.9%-13013.4%-17034.3%-43164.6%-71884.0%
Net margin-39417.3%-42724.7%-11843.8%-16487.3%-42693.9%-79392.0%
FCF margin-32529.6%-18500.0%-8926.8%-13209.3%-40170.7%-68068.0%
Return on assets-31.3%-45.3%-38.0%-38.0%-23.8%-134.1%
Return on equity-42.3%-68.8%-51.7%-44.7%-25.3%15.8%
Current ratio1.691.922.515.8013.111.22

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.